In the TME, statins can reduce tumor cell proliferation, promote apoptosis, induce autophagy, reduce migration and invasion, and promote anti‐inflammatory immunomodulation by affecting key proteins such as Ras, RhoA/C, Rac, and Rab [246]. Here, AKT1 is linked to neoplasm.